mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.1 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.2 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.2 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.2 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.2 |
mRNA |
gossypol |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |